NecroIr2 - ≥98% , CAS No.N658812

CAS: N658812 Cat. No.: N658812 Formula: C₄₆H₃₀ClIrN₆O₂^- Peso molecolare: 926.44

QUALITÀ & PUREZZA ≥98%

Storage

Store at 2-8°C,Protected from light,Desiccated

Shipped In

Wet ice

Panoramica

NecroIr2 is an iridium(III) complex, serves as necroptosis inducers in Cisplatin ( HY-17394 )-resistant lung cancer cells (A549R). NecroIr2 selectively accumulates in mitochondria, leading to oxidative stress and loss of mitochondrial membrane potential (

Appearance:Solid

IC50& Target:CDK4 RIPK3 RIPK1

In Vitro:NecroIr2 (2 μM; 1-2 d) exerts subcellular distribution over 90% accumulated in mitochondria in non-labelled A549R and CFSE labelled L02 cells. NecroIr2 (1.5 μM and 3 μM; 24 h) results ROS generation increasing and loss of mitochondrial membrane poten

Biological Activity:NecroIr2 is an iridium(III) complex, serves as necroptosis inducers in Cisplatin ( HY-17394 )-resistant lung cancer cells (A549R). NecroIr2 selectively accumulates in mitochondria, leading to oxidative stress and loss of mitochondrial membrane potential (

Specifiche

Specifiche e purezza

≥98%

Condizioni di conservazione di stoccaggio

Store at 2-8°C,Protected from light,Desiccated

Spedito in

Wet ice

Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.

Purezza

≥98%

Nomi e identificatori

Sorrisi canonici

C1(C2=NC(C=CC=C3)=C3O2)=CC(C4=[N]5C=CC(C6=NC(C=CC=C7)=C7O6)=C4)=[N]([Ir]89([N]%10=CC=CC=C%10C%11=C9C=CC=C%11)5[N]%12=CC=CC=C%12C%13=C8C=CC=C%13)C=C1.[Cl-].[+]

Peso molecolare

926.44

Proprietà chimiche e fisiche

• Solubilità: DMSO : 50 mg/mL (53.97 mM; Need ultrasonic)

Application Protocols

No validated application protocols are provided for this listing.

• Item-specific data:

  • Tested applications, recommended concentrations, and assay conditions: Not specified for this item; refer to CoA/Spec Sheet.

• General usage template (non-item-specific):

  • Stock preparation: Dissolve in anhydrous DMSO to prepare a 10–50 mM stock (or as solubility allows). Vortex and, if needed, sonicate briefly. Protect from light.
  • Working solution: Dilute stock into pre-equilibrated buffer or media to the required final concentration, keeping DMSO ≤0.5–1% v/v. Mix thoroughly to avoid local supersaturation.
  • Controls: Include vehicle-only controls and, where applicable, a known reference compound.
  • Documentation: Record lot number, stock concentration, preparation date, and storage conditions on every aliquot.

• Important note:

  • Refer to the product-specific CoA/SDS for any handling limits or restrictions and perform pilot experiments to ensure compatibility with your assay platform.

Biological Roles

No biological role, target, or pathway association is specified for this item in the Product Data.

• Item-specific status:

  • Biological function/target: Not specified for this item; refer to CoA/Spec Sheet or primary literature if available for your project.

• General guidance (non-item-specific):

  • Prior to biological testing, confirm compound identity/purity and assess DMSO stock stability by LC–MS over the expected storage period.
  • Evaluate cytotoxicity and nonspecific effects in your cell system using appropriate controls (vehicle control, positive/negative reference standards).
  • If the compound is fluorescent or photosensitive, characterize spectral properties and phototoxicity under assay illumination to avoid confounding results.
  • Consider potential aggregation in aqueous media; use detergent-free assays or include low levels of nonionic surfactant after verifying lack of assay interference.

• Documentation:

  • Annotate all experimental outcomes with lot number, stock age, solvent composition, and light exposure history to ensure reproducibility.

Buffer Applications

This listing does not provide buffering characteristics or pKa information; the compound is not presented as a buffer component.

• Item-specific data: Not specified for this item; refer to CoA/Spec Sheet.

• Practical guidance (general, for handling small molecules in buffers):

  • Prepare a concentrated DMSO stock, then dilute into the desired biological buffer to a final DMSO content typically ≤0.5–1% v/v.
  • Common assay buffers include PBS (pH ~7.4), HEPES (pH 7.0–7.6), or Tris (pH 7.2–8.0). Select buffer components that do not spectrally interfere if optical readouts are used.
  • To minimize precipitation upon dilution, add the DMSO stock slowly to vigorously mixed buffer and maintain temperature consistency; brief sonication can help if needed.
  • Filter-sterilize the final working solution through a compatible 0.22 µm membrane if required by the assay, and verify that filtration does not remove the analyte (mass balance check).

Green Alternatives

Item-specific green metrics (e.g., EHS profile, synthesis footprint) are not provided. The solvent and handling choices around small-molecule library compounds can be optimized for greener practice.

• Greener solvent considerations (general):

  • Prefer water or aqueous buffers where feasible; limit DMSO content to the minimum compatible with solubility and assay performance.
  • Where an aprotic polar solvent is required, consider dimethyl sulfone (low volatility) or propylene carbonate as alternatives in some workflows; confirm compatibility empirically.
  • Replace DMF/NMP with safer/high-boiling alternatives (e.g., Cyrene, GBL) when only a processing solvent is needed and chemical compatibility allows.

• Operational improvements:

  • Use micro-scale assays and miniaturized plates to reduce solvent consumption and waste.
  • Implement closed amber vials and efficient light shielding rather than repeated foil wraps, reducing lab waste and improving consistency.
  • Consolidate solvent streams for more efficient hazardous waste segregation.

• Example comparison (general, not item-specific):

  • DMSO vs DMF/NMP: DMSO typically offers lower toxicity and excellent solvency; choose DMSO first for stock solutions. Reserve DMF/NMP for cases where DMSO solubility is inadequate.

• Documentation:

  • Record solvent choices and volumes to support green metrics reporting and continuous improvement.

Pharmaceutical Uses

No pharmacopeial status, excipient role, or manufacturing application is provided for this item. This product is supplied strictly for research use only (as stated in Product Data) and is not for human or veterinary use.

• Item-specific status:

  • Regulatory listing/monograph: Not specified for this item; refer to CoA/Spec Sheet.
  • Excipient or process role: Not specified for this item; refer to CoA/Spec Sheet.

• General guidance (non-clinical):

  • For pre-formulation research, confirm solubility, stability, and compatibility with proposed excipients using small-scale screening.
  • Maintain detailed records (lot, purity, solvent history) when generating data intended to inform later development of related chemical matter under GLP/GMP conditions.
  • Do not use this material in clinical or diagnostic applications without appropriate qualification and regulatory review.

Physical Properties

Key item-specific properties have not been disclosed for this catalog entry.

• Item-specific data (from Product Data):

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.

• Commonly referenced physical parameters (not provided for this item):

  • Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • logP/logD: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index/UV cutoff: Not specified for this item; refer to CoA/Spec Sheet.

• Practical laboratory guidance (general, not item-specific):

  • For small-molecule library members of unknown polarity, initial solubility screening typically starts with DMSO (e.g., 10–50 mg/mL), followed by dilution into aqueous buffers with 0.1–1% DMSO.
  • If the material is a dye or photosensitive probe, protect from light during weighing, dissolution, and storage (amber vials).
  • If hygroscopic, handle quickly in a desiccated environment and record mass promptly.
  • For method development, use analytical LC–MS and 1H NMR to confirm identity and assess purity before scale-up or screening.

Quality and Grades

Quality designations and analytical specifications for this item are not listed in the Product Data.

• Item-specific status:

  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Any stabilizer/additives: Not specified for this item; refer to CoA/Spec Sheet.

• Guidance on interpretation (general, for small-molecule libraries):

  • Library compounds are commonly qualified by LC–MS (identity, [M+H]+), 1H NMR (key resonances/integrity), and chromatographic purity (e.g., HPLC/UPLC area%). UV/Vis profiles may be included for chromophoric compounds.
  • If “screening grade” or similar is provided on the CoA, expect suitability for in vitro screening with typical purity ≥90% by HPLC unless otherwise stated. For mechanistic or in vivo-like research, users often require ≥95–98% purity; verify and repurify if necessary.
  • Low-water/low-residual-solvent requirements, metal content, and specific contaminants (e.g., peroxides for ethers) are not applicable here unless explicitly listed on the CoA.

• Recommendations:

  • Request the latest CoA/SDS before critical experiments.
  • If running sensitive assays (e.g., fluorescence or chemiluminescence), confirm absence of interfering impurities by orthogonal methods (HPLC-UV/FLR, LC–MS, NMR).
  • Retain aliquots of each lot for cross-comparison in long studies.

Reaction and Applications

No manufacturer application notes are provided for this entry beyond its inclusion in a small-molecule/compound library. The following guidance is general and non-item-specific.

• Research usage context (general):

  • Library compounds are commonly applied in phenotypic or target-based screening, chemical biology probes, or method controls. Prior to deployment, confirm identity and purity by LC–MS/NMR and conduct small-scale solubility and stability assessments under assay conditions.

• If the compound is a chromophore or photosensitive entity (suggested by light-protected storage):

  • Evaluate absorption/emission spectra in intended solvents to identify analytical windows and avoid spectral overlap with assay dyes.
  • Assess photostability under experimental illumination; consider neutral density filters or minimized exposure.

• Not a general-purpose reagent:

  • In the absence of structural information, do not assume suitability for named reactions or as a synthetic building block. If synthetic transformations are planned, first determine functional-group compatibility and stability via small trials.

• Practical workflow tips:

  • Prepare concentrated DMSO stocks, aliquot, and freeze to minimize freeze–thaw cycles.
  • For screening, build serial dilutions shortly before use and confirm concentration by UV/Vis or quantitative NMR if feasible.
  • Track lot numbers and retain analytical records for reproducibility.

Reaction Conditions

No reaction conditions are provided, and the compound is not presented as a reagent in the Product Data. Consequently, standardized reaction parameters cannot be recommended for this item.

• Item-specific data: Not specified for this item; refer to CoA/Spec Sheet.

• General guidance (method development when structure is unknown):

  • If exploring stability or potential derivatization, start with mild conditions, monitor by LC–MS, and incrementally vary pH, temperature, and solvent composition.
  • Protect from light and moisture per storage guidance during any experimental procedure.
  • Use inert atmosphere (N2/Ar) if sensitivity to oxygen is suspected based on preliminary tests (color change, rapid degradation).

Safety and Handling

Safety profile information for this specific item has not been provided in the Product Data. Always consult the product-specific SDS before use.

• Item-specific hazard data (from Product Data):

  • Signal Word: Not specified for this item; refer to SDS.
  • H-Statements: Not specified for this item; refer to SDS.
  • GHS Classification: Not specified for this item; refer to SDS.
  • Pictograms: Not specified for this item; refer to SDS.

• General laboratory precautions (not item-specific):

  • Wear appropriate PPE: lab coat, safety glasses, and chemical-resistant gloves. Work in a fume hood when dusts, vapors, or aerosols could be generated.
  • Avoid inhalation, ingestion, and skin/eye contact. Wash thoroughly after handling.
  • If photosensitive (storage guidance suggests light sensitivity), minimize light exposure; use amber containers and shielded lighting.
  • If moisture sensitive (desiccated storage indicated), handle under low humidity; recap promptly and store with desiccant.

• First-aid overview (consult SDS for specifics):

  • Eye/skin contact: Rinse with water for at least 15 minutes; remove contaminated clothing; seek medical attention if irritation persists.
  • Inhalation: Move to fresh air; seek medical attention for symptoms.
  • Ingestion: Rinse mouth; do not induce vomiting unless directed; seek medical attention.

• Incompatibilities and waste (general):

  • Until specific data are available, segregate from strong oxidizers and acids/bases as a precaution. Dispose according to institutional hazardous waste procedures and local regulations.

Solvent Selection

No item-specific solubility profile is provided. The following is general guidance for small-molecule library compounds and light-/moisture-sensitive materials.

• Primary stock solvent strategy (general):

  • Start with anhydrous DMSO for 10–50 mg/mL stocks. If insoluble, test DMF, NMP, or a co-solvent blend (e.g., DMSO:ACN 1:1).
  • For aqueous use, dilute DMSO stocks into buffer to a final DMSO content typically ≤0.5–1% v/v to minimize biological assay artifacts.

• Polarity/partitioning (unknown for this item):

  • If the compound shows poor DMSO solubility, consider adding a small percentage of co-solvents (ACN, IPA) or using gentle heating/sonication. Avoid prolonged high heat for photosensitive compounds.

• Miscibility and compatibility:

  • DMSO, DMF, NMP are miscible with water and many organic solvents; they facilitate serial dilutions and plating.
  • For formulations requiring minimal DMSO, cyclodextrin inclusion or surfactant-assisted solubilization (e.g., 0.01–0.1% Tween 80) can be explored after compatibility checks.

• Practical tips:

  • Use amber vials and minimize headspace for light-/air-sensitive compounds; flush with inert gas if warranted by stability tests.
  • Filter through low-binding 0.22 µm PTFE/RC syringes if particulate forms. Validate that filtration does not adsorb analyte (mass balance check by HPLC).

Storage and Reconstitution

This product is supplied for research use only. Storage guidance is provided in the Product Data; follow strictly to maintain integrity.

• Item-specific storage (from Product Data):

  • Store at 2–8°C.
  • Protect from light.
  • Store desiccated (low humidity).
  • Shipped on wet ice.

• Reconstitution (item-specific details not provided):

  • Solvent choice and concentration: Not specified for this item; refer to CoA/Spec Sheet.

• General reconstitution guidance (non-item-specific):

  • Use anhydrous, oxygen-free solvent if stability is a concern; DMSO is a common first choice for small molecules. Prepare concentrated stocks (e.g., 10–50 mM) in amber vials.
  • Allow vials to equilibrate to room temperature in the dark before opening to minimize moisture condensation. Open quickly, weigh accurately, and recap immediately.
  • After dissolution, aliquot into light-protective, low-binding microtubes to avoid repeated freeze–thaw. Label aliquots with lot, concentration, and date.

• Stability monitoring:

  • Periodically check by LC–MS or HPLC for degradation, especially if the compound is photosensitive or hygroscopic.
  • Discard aliquots showing precipitation, discoloration, or unexpected chromatographic changes.

• Note:

  • For definitive specifications (solubility limits, stability in specific solvents, recommended stock concentrations), consult the CoA/Spec Sheet.

Structure and Identity

Concise overview: NecroIr2 is listed in our small-molecule/compound library category. Detailed structural identifiers have not been provided for this catalog entry.

• Item-specific (from Product Data):

  • Product Name: NecroIr2
  • SKU: N658812
  • CAS: N658812 (as listed in catalog)
  • Category: Small molecules and compound library (全部 / 可售 / 小分子和化合物库)
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

• Structural features (general guidance):

  • Not specified for this item. If structure is required for compliance, method development, or registration, request the current CoA/SDS or structural disclosure from Aladdin Scientific.

• 2D structure description:

  • Not available for this listing. No ring systems, functional groups, or stereochemical descriptors are provided in the Product Data.

• Notes on naming (general comment, not item-specific):

  • The name “NecroIr2” suggests a specialized research compound, potentially used in cell-death pathway research, but this is not confirmed in the Product Data. Users should verify identity and intended application via CoA/SDS or internal characterization (e.g., LC–MS, NMR) before critical experiments.

Synthetic Utility

The Product Data do not indicate that NecroIr2 is intended as a synthetic reagent or building block. Without structural information, specific reactivity patterns cannot be assigned.

• Item-specific status:

  • Functional groups/reactivity: Not specified for this item; refer to CoA/Spec Sheet.

• General considerations (if synthetic derivatization is contemplated):

  • Obtain or elucidate the structure (LC–MS, HRMS, NMR, elemental analysis). Identify labile moieties and photolability prior to planning transformations.
  • Conduct micro-scale test reactions to probe stability toward base, acid, nucleophiles/electrophiles, and redox conditions.
  • If the compound carries chromophores or metal centers (not confirmed here), be mindful of ligand exchange, redox states, and light-induced processes that can complicate synthetic steps.
  • Establish analytical methods (orthogonal HPLC methods, LC–MS, UV/Vis) to track conversions and impurities during any derivatization attempts.

Target Specificity

No target, binding profile, or selectivity information is provided in the Product Data for this item.

• Item-specific data:

  • Target/Pathway: Not specified for this item; refer to CoA/Spec Sheet.
  • Species reactivity/assay context: Not specified for this item; refer to CoA/Spec Sheet.

• Guidance (general):

  • If used in target-based studies, determine potency and selectivity using appropriate biochemical/cellular assays with positive and negative controls.
  • Validate on- vs off-target effects through orthogonal methods (e.g., genetic perturbation, chemical rescue, counter-screens) before drawing mechanistic conclusions.

Domande frequenti

What is the purity of this product?

This product is supplied at ≥98% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.

How should this product be stored?

Store at 2–8 °C, protected from light, desiccated. Keep the container tightly closed with desiccant — the material is moisture-sensitive.

How is this product shipped?

This product ships chilled on wet ice. Unpack on arrival and transfer it to the storage condition stated above.

What are the CAS number, molecular formula and molecular weight?

The CAS Number is N658812, the molecular formula is C46H30ClIrN6O2-, and the molecular weight is 926.44 g/mol.

What documentation is provided?

Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.